Accepted article                   Back to the articles list | Back to browse issues page

XML Print


1- Department of Psychology, Ahv.C., Islamic Azad University, Ahvaz, Iran
2- Department of Psychology, Ahv.C., Islamic Azad University, Ahvaz, Iran , fhaffezi@gmail.com
3- Department of psychology, Ramh.C., Islamic Azad University, Ramhormoz, Iran
Abstract:   (22 Views)
Objective: This study compared the effectiveness of Acceptance and Commitment Therapy (ACT) and the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) on emotional expressivity in women diagnosed with social anxiety disorder (SAD).
Methods: This clinical trial employed a pretest-posttest design with a three-month follow-up and a control group. The study population included women aged 20–40 with a confirmed SAD diagnosis based on the Structured Clinical Interview for DSM-5 and elevated Social Phobia Inventory scores, recruited via convenience sampling from counseling clinics in Ahvaz, Iran, in 2024. Forty-five participants were randomly assigned to three groups (ACT, UP, or control), each with 15 participants. The ACT and UP groups received eight 90-minute weekly sessions, while the control group remained on a waiting list. Emotional expressivity was assessed using the Emotional Expressivity Scale (EES). Data were analyzed using repeated measures ANOVA.
Results: Both ACT and UP led to significant improvements in emotional expressivity and its subscales (positive, intimacy, and negative expressivity) compared to the control group, with gains sustained at follow-up. Notably, both interventions were equally effective in enhancing emotional expressivity. These findings highlight the clinical utility of ACT and UP in improving social functioning for women with SAD.
Conclusion: ACT and UP are equally effective in fostering lasting improvements in emotional expressivity, offering valuable therapeutic options for SAD.
 
     
Type of Study: Original Research Article | Subject: Family and group therapy
Received: 2025/08/6 | Accepted: 2025/09/28

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb